Please find enclosed the newspaper advertisement for the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30-September-2025 published in Mumbai ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries Ltd has submitted to BSE the newspaper clippings of its Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended 30 September 2025. The results were published in two newspapers — Mumbai Lakshadeep and Financial Express — on 20 October 2025. The filing is a regulatory compliance submission under SEBI Listing Regulations, attaching copies of the already-disclosed financial results as published in print media. No new financial figures or guidance are introduced in this filing beyond what was previously disclosed to the exchanges. The company's BSE scrip code is 543828 with ISIN INE00TV01023.
This is a routine compliance filing with no fresh financial information for shareholders. The underlying Q2/H1 FY26 results would have already been disclosed earlier, so this announcement is unlikely to move the share price.